SPDR S&P Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in SPDR S&P Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including SPDR S&P Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in SPDR S&P Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.8M | 59k | 47.94 |
| 2025-03-31 | $2.3M | 52k | 43.80 |
| 2024-12-31 | $2.3M | 53k | 42.99 |
| 2024-09-30 | $197k | 4.4k | 44.36 |
| 2024-06-30 | $130k | 3.3k | 39.78 |
| 2024-03-31 | $43k | 990 | 43.13 |
| 2023-12-31 | $380k | 9.1k | 41.62 |
| 2023-09-30 | $14k | 339 | 39.75 |
| 2023-06-30 | $14k | 339 | 40.99 |
| 2023-03-31 | $16k | 399 | 40.10 |
| 2022-12-31 | $14k | 339 | 41.30 |
| 2022-06-30 | $4.4M | 104k | 41.95 |
| 2022-03-31 | $2.7M | 60k | 45.27 |
| 2021-12-31 | $1.3M | 28k | 46.09 |
| 2021-03-31 | $4.3M | 85k | 50.24 |
| 2020-12-31 | $16M | 299k | 52.06 |
| 2020-09-30 | $14M | 327k | 42.94 |
| 2020-06-30 | $18M | 410k | 42.97 |
| 2020-03-31 | $21M | 587k | 36.07 |
| 2019-12-31 | $6.0k | 134 | 44.78 |
| 2019-09-30 | $42M | 1.1M | 37.31 |
| 2019-06-30 | $13M | 350k | 37.31 |
| 2019-03-31 | $4.5M | 100k | 44.78 |
| 2018-12-31 | $8.3M | 238k | 34.88 |
| 2018-09-30 | $5.5M | 119k | 46.51 |
| 2018-06-30 | $206k | 4.8k | 43.26 |
| 2018-03-31 | $313k | 7.5k | 41.80 |
| 2017-12-31 | $798k | 18k | 43.38 |
| 2017-06-30 | $381k | 8.9k | 43.05 |
| 2017-03-31 | $1.2M | 30k | 41.81 |
| 2016-12-31 | $765k | 20k | 39.11 |
| 2016-09-30 | $809k | 18k | 44.19 |
| 2016-06-30 | $747k | 18k | 41.78 |
| 2016-03-31 | $528k | 13k | 40.23 |
| 2015-12-31 | $675k | 13k | 51.67 |
| 2015-06-30 | $617k | 5.0k | 123.33 |
| 2014-12-31 | $458k | 4.3k | 106.67 |